• P. Balamurugan Department of Chemistry, Sathyabama University, Jeppiar Nagar, Chennai–119,
  • K. Anver Bash Department of Chemistry, C. Abdul Hakeem College, Melvisharam, Tamilnadu
  • Jeenet Jayachandran Analytical Research and Development Department, Cipla Ltd, Bangalore-49
  • Manish Gangrade Analytical Research and Development Department, Cipla Ltd, Bangalore-49
  • P. Parthiban Centre for Research and Development, PRIST University, Thanjavur, Tamilnadu


Objective: To develop a simple and accurate RP-HPLC method for simultaneous estimation of organic impurities, enantiomer and assay of Dexlansoprazole, proposed method was validated according to an International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) guidelines.

Methods: Cellulose tris-(3,5-dichlorophenylcarbamate) bonded on silica gel (Chiralpak IC) were used as stationary phase. Acetonitrile (ACN) and 10 mM dibasic potassium phosphate buffer of pH 7.20, adjusted with dilute ortho phosphoric acid, were used as mobile phase in gradient composition at a flow rate of 1.0 ml/min. UV detection was made at 283 nm and run time was 27 min.

Results: Limit of detection (LOD) and Limit of quantification (LOQ) was 42 and 126 ng/ml, respectively. Analytes response was studied from 0.25-1.50 µg/ml and r2 value of the calibration curve was>0.999. Accuracy was studied in three different concentrations, the mean recovery was observed between 93.8 and 102.5%. To the maximum of 0.01% impurity variation was observed between the results of inter and intra-day precision.

Conclusion: Proposed method is specific, precise, sensitive, linear and accurate. As a significance of this proposed method, the listed known impurities of Lansoprazole monograph [United States, British and European pharmacopoeias (USP/BP/Ph. Eur.)] Were used in method development and separation was demonstrated. Apart from this, enantiomer resolution was achieved and the same chromatogram was used for assay calculation.


Keywords: Chiralpak IC, Cellulose tris-(3, 5-dichlorophenylcarbamate), Dexlansoprazole, Method development, Simultaneous estimation, Lansoprazole


Download data is not yet available.


1. Andersson T. Single-Isomer drugs true therapeutic advances. Clin Pharmacokinet 2004;43:279-85.
2. Khorassani MA, Taylor LT, Williams DG, Roston DA, Catalan TT. Demonstrative validation study employing a packed column pressurized fluid chromatography method that provides assay, achiral impurities, chiral impurity, and IR identity testing for a drug substance. J Pharm Biomed Anal 2001;26:725-38.
3. Perara RWH, Lough WJ. Assessment of chiral stationary phases for suitability for combined enantiomeric impurity/related substances assays. J Chromatogr A 2011;1218:8655-63.
4. Zhang T, Nguyen D, Franco P. RP-screening strategies for liquid chromatography on polysaccharide-derived chiral stationary phases. J Chromatogr A 2010;1217:1048-55.
5. Miura M, Tada H, Suzuki T. Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction. J Chromatogr B 2004;804:389-95.
6. Karol MD, Granneman GR, Alexander K. Determination of lansoprazole and five metabolites in plasma by HPLC. J Chromatogr B 1995;668:82-186.
7. Al-zehouri J, El-subbagh HI, Al-badr AA. Analytical profiles of drug substances and excipients; 2001;28:117-51.
8. Uno T, Yasui-Furukori N, Takahata T, Sugawara K, Tateishi T. Determination of lansoprazole and two of its metabolites by liquid–liquid extraction and automated column-switching HPLC: application to measuring CYP2C19 activity. J Chromatogr B 2005;816:309-14.
9. Song M, Gao X, Hang T, Wen A. Simultaneous determination of lansoprazole and its metabolites 5-hydroxy lansoprazole and lansoprazole sulphone in human plasma by LC–MS/MS: Application to a pharmacokinetic study in healthy volunteers. J Pharm Biomed Anal 2008;48:1181-6.
10. Hishinuma T, Suzuki K, Yamaguchi H, Yamagishi H, Koike T, Ohara S, et al. Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. J Chromatogr B 2008;870:38-45.
11. Luo Y, Xu L, Xu M, Feng J, Tang X. A validated, Specific, Stability-indicating HPLC method for determination of Lansoprazole enteric capsules and related impurities. Asian J Pharm Sci 2012;7:149-54.
12. USP monograph 37 and NF 32.
13. Ramulu K, Rao BM, Rao NS. Identification, Isolation and characterization of potential degradation products in Lansoprazole drug substance. Rasayan J Chem 2013;6:274-83.
14. Pai NR, Patil SS. Development and validation of a liquid chromatography method for the analysis of Lansoprazole and its related production impurities. J Chem Pharm Res 2013;5:121-8.
15. Katsuki H, Hamad A, Nakamur C, Arimori K, Nakano M. HPLC assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes. J Chromatogr B 2001;757:127–33.
16. Miura M, Tada H, Satoh S, Habuchi T, Suzuki T. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction. J Pharm Biomed Anal 2006;4:565-70.
17. Rao RN, Raju AN, Nagaraju D. Enantiospecific resolution of rabeprazole by liquid chromatography on amylose-derived chiral stationary phase using PDA and polarimetric detectors in series. Talanta 2006;70:805-10.
18. Belaz KRA, Coimbra M, Barreir JC, Montanari CA, Cass QB. Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase. J Pharm Biomed Anal 2008;47:81-7.
19. Cirilli R, Ferretti R, Gallinella B, Turchetto L, Zanitti L, Torre FL. Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)-and (S)-(−)-lansoprazole enantiomers and related impurities. J Pharm Biomed Anal 2009;50:9-14.
20. Zanitti L, Ferretti R, Gallinella B, Torre FL, Sanna ML, Mosca A, et al. Direct HPLC enantioseparation of omeprazole and its chiral impurities: Application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate. J Pharm Biomed Anal 2010;52:665-71.
21. Cirilli R, Ferretti R, Gallinella B, Zanitti L. Retention behaviour of proton pump inhibitors using immobilized polysaccharide-derived chiral stationary phases with organic-aqueous mobile phases. J Chromatogr A 2013;1304:147-53.
22. Chennuru LN, Choppari T, Duvvuri S, Dubey PK. Enantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography. J Sep Sci 2013;36:3004-10.
23. Dixit S, Dubey R, Bhushan R. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of Dexrabeprazole. Biomed Chromatogr 2014;28:112-9.
24. Peng L, Jayapalan S, Chankvetadze B, Farkas T. Reversed-phase chiral HPLC and LC/MS analysis with tris-(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. J Chromatogr A 2010;1217:6942-55.
25. Zhang T, Nguyen D, Franco P. Enantiomer resolution screening strategy using multiple immobilised polysaccharide-based chiral stationary phases. J Chromatogr A 2008;1191:214-22.
1128 Views | 2221 Downloads
How to Cite
Balamurugan, P., K. A. Bash, J. Jayachandran, M. Gangrade, and P. Parthiban. “A SIMPLE RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ORGANIC IMPURITIES, ENANTIOMER AND ASSAY OF DEXLANSOPRAZOLE”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 7, no. 9, July 2015, pp. 347-52, https://innovareacademics.in/journals/index.php/ijpps/article/view/7308.
Original Article(s)